The potential role of TRPV1 in pulmonary hypertension: Angel or demon?

Channels (Austin). 2019 Dec;13(1):235-246. doi: 10.1080/19336950.2019.1631106.

Abstract

Pulmonary hypertension (PH) is a pathological state defined by increased pulmonary artery pressure, the pathogenesis of which is related to genetic mutations, intracellular calcium ([Ca2+]i), inflammation and proliferation. Transient receptor potential vanilloid subfamily member 1 (TRPV1) is a nonselective cation channel expressed in neural and nonneural cells, including pulmonary vessels and nerves. As a calcium channel, TRPV1 can make vessels contracted, and promote smooth muscle cells proliferation through calcium-dependent transcription factors. Activation of TRPV1 in sensory nerves can release neuropeptides, including calcitonin gene-related peptide (CGRP), substance P (SP), and somatostatin (SST), which can regulate inflammation via transcription factor NF-kB. Considering the increased level of [Ca2+]i and inflammation in the pathogenesis of PH, our review summarizes the role of TRPV1 in PH with regard to [Ca2+]i, neuropeptides, and inflammation. In view of the limited research illustrating the relationship between TRPV1 and PH directly, our review also considers the role of TRPV1 in other types of vascular inflammation. Through this review, we hope to raise awareness about the function of TRPV1 in PH.

Keywords: Ca; Pulmonary hypertension; inflammation; neuropeptides; transient receptor potential vanilloid subfamily member 1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Calcium / metabolism
  • Humans
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / metabolism*
  • Neuropeptides / metabolism
  • TRPV Cation Channels / genetics
  • TRPV Cation Channels / metabolism*

Substances

  • Neuropeptides
  • TRPV Cation Channels
  • TRPV1 protein, human
  • TRPV1 receptor
  • Calcium

Grants and funding

This study was supported by the National Natural Science Foundation of China under Grant No. 81670447; the National Natural Science Foundation of Zhejiang Province under Grant No. LY15H020006; Zhejiang Province Key Subject of Medicine (Neurological Rehabilitation) and the Traditional Chinese Medicine Program of Zhejiang Provincial under Grant No. 2017ZZ001; the Zhejiang Provincial Health Commission Project under Grant No. 2017KY559. Li-hong Wang is sponsored by Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents.